STUDY QUESTION: Does in vitro fertilization (IVF) affect the course of anxiety and depressive symptoms as well as physiological stress from pregnancy to postpartum period?
Introduction
An IVF pregnancy can be a stressful process due to the fact that it involves some risks, such as medical complications, multiple pregnancies, an increase in preterm births and neurodevelopmental disorders in infants (Ramoğlu et al., 2016) . There is, however, no follow-up study about the IVF effect on the mental health status from pregnancy to postpartum. We have done so by adopting simultaneous measurement of self-reported symptoms and stress biomarkers .
Mental health status after successful IVF treatment has been usually assessed in terms of self-reported pregnancy-specific anxiety, general anxiety and depression in cross-sectional studies (Gourounti, 2016) . As for pregnancy-specific anxiety, IVF women report greater levels than natural conception women (Gourounti, 2016) . Nevertheless, studies addressing anxiety and depression in IVF women have shown inconclusive results, which could be due to potential confounding variables, such as age, parity (García-Blanco et al., 2017a) , multiple pregnancy (Tendais and Figueiredo, 2016) and time of testing (Gourounti, 2016) .
With respect to anxiety symptoms, while some studies found that IVF women exhibited the same or higher anxiety levels (Klock and Greenfeld, 2000; Hjelmstedt et al., 2003a,b; Cox et al., 2006; HarfKashdaei and Kaitz, 2007; Monti et al., 2008; Gameiro et al., 2010; Gourounti et al., 2013; Hashemiech et al., 2013; Darwiche et al., 2014) , others reached opposite conclusions (Repokari et al., 2005; Punamäki et al., 2006; McMahon et al., 2013) . Concerning depressive symptoms, while most studies found that IVF women exhibited the same or lower depression levels from pregnancy (Punamäki et al., 2006; Harf-Kashdaei and Kaitz, 2007; Fisher et al., 2008; Gameiro et al., 2010; McMahon et al., 2013; Lynch and Prasad, 2014) to postpartum (Repokari et al., 2005; Monti et al., 2015) , others did not replicate these findings (Monti et al., 2009) . It is noteworthy that the studies that did not replicate the main findings (Repokari et al., 2005; Punamäki et al., 2006; Monti et al., 2009; McMahon et al., 2013) examined patients treated with assisted reproduction techniques without differentiating the type of technique.
Among potential confounding variables, the time of testing may clarify these findings in IVF women. Although anxiety symptoms can be higher during pregnancy due to potential fetal health complications (Glazebrook et al., 2001; Hammarberg et al., 2008) , they can decrease rapidly after giving birth without complication (Jongbloed-Pereboom et al., 2012; García-Blanco et al., 2017a) . Conversely, depressive symptoms can be lower during pregnancy because of the increase of happiness after a successful IVF (Ulrich et al., 2004) . Moreover, IVF mothers may show higher resilience during motherhood due to the fact that they have already faced negative emotions during the infertility period (Harris, et al., 1991; Sandelowski et al., 1992; Repokari et al., 2005) .
Concerning stress biomarkers, the hypothalamus pituitary adrenal (HPA) axis and the sympathetic adrenal medullary (SAM) axis are the two major physiological systems involved in the stress response (García-Blanco et al., 2017b) . Whereas the HPA axis is regulated by cortisol (Hellgren et al., 2016) , the SAM axis is regulated by catecholamines (i.e. norepinephrine), which are related to α-amylase levels (Giesbrecht et al., 2013) . The existing literature emphasizes on the increase in cortisol and catecholamines levels during the IVF treatment (Massey et al., 2016; An et al., 2013) . It is, however, yet to be evaluated (that whether) (if) the impact of IVF treatment extends beyond the perinatal period and predicts a maladaptive course of stress biomarkers after successful pregnancy.
To our knowledge, this is the first follow-up study that evaluates simultaneously anxiety and depressive symptoms and cortisol and α-amylase levels comparing a large sample of pregnant women after successful IVF and those who conceived naturally from pregnancy to postpartum. As for psychological symptoms, we hypothesized that IVF women show higher anxiety levels (Glazebrook et al., 2001; Hammarberg et al., 2008) , and lower depressive symptoms (Ulrich et al., 2004) at the third trimester of pregnancy. After pregnancy, IVF mothers may be more resilient and show similar, even lower, decrease in anxiety and depression levels (Harris et al., 1991; Sandelowski et al., 1992; Repokari et al., 2005; Jongbloed-Pereboom et al., 2012) . In relation to stress biomarkers, we hypothesized that IVF women show higher levels (Smeenk et al., 2005) at the third trimester of pregnancy, which may be maintained postpartum due to a maladaptive course of stress response.
Materials and Methods

Study design and participants
This is a prospective cohort study performed in the Division of Obstetrics of the University and Polytechnic Hospital La Fe (Valencia, Spain) during a 12-month period in 2015. Participants were recruited during the third trimester of pregnancy to guarantee fetal viability. The follow-up was carried out at three different assessment times: (i) time#1 (T1) at the third trimester of pregnancy, (ii) time#2 (T2) at 48 h after birth and (iii) time#3 (T3) at 3 months after birth.
Eligible participants included pregnant women who were unaffected by pre-existing major medical disorders that require close supervision during pregnancy (e.g. heart disease, high blood pressure, type I diabetes, severe mental illness…). Participants were classified into two groups: pregnant women after successful IVF (n = 62) and pregnant women who conceived naturally (n = 189). An obstetrician confirmed that the participants met the inclusion criteria based on a case note review. Participants who fulfilled the eligibility criteria were interviewed by a clinical psychologist at T1, at the Maternity Inpatient Unit at T2 and at the Maternity Outpatient Unit at T3 in order to obtain the socio-demographic and perinatal information, which was completed by a chart review of hospital medical records.
The exclusion criteria included substance consumption during pregnancy since this could affect the HPA and SAM axes. Moreover, the natural conception participants should not be younger than 24 years of age (the estimated age of the youngest participant in the IVF group) and no participants should be pregnant by other types of assisted reproduction (e.g. ovulation induction or artificial insemination). The final sample consisted of 243 pregnant women (60 IVF and 183 natural conceptions). Fig. 1 shows a flow diagram of the recruitment.
Ethical approval
The ethics committee of the University and Polytechnic Hospital La Fe (Valencia; Spain) approved the study and all participants signed an informed consent.
Procedures
Psychological assessment
Patients' current anxiety state was measured by the Spanish version of the State form from the State-Trait Anxiety Inventory (STAI) (Spielberger et al., 1970; Spielberger et al., 1982) . It can be used in clinical settings to diagnose anxiety and to distinguish anxious from depressive symptoms. It comprised 20 items assessing current tension, nervousness and concerns, on a 4-point Likert scale (i.e. from '0 = Almost Never' to '3 = Almost Always'). Scores ranged from 0 to 60, with higher scores indicating greater anxiety symptoms. The threshold for clinical anxiety is a total score of 19. The internal consistency coefficient for the scale was 0.89 in our sample population.
The Spanish version of the Beck Depression Inventory-Short Form (BDI/SF) (Beck et al., 1997; Conde and Useros, 1975 ) was used to measure the intensity of attitudes and depressive symptoms and to detect depression in the general population. It contains 13 items, rated on a 4-point Likert scale, from 0 (low) to 3 (high). Scores ranged from 0 to 39, with higher scores indicating higher depressive symptoms. The threshold for clinical depression is a total score of 4. Our sample population demonstrated an internal consistency for the BDI of 0.73.
Additionally, their personal history of exposure to traumatic eventssuch as sexual trauma, accidents, natural disasters or tragic death-was assessed because they are associated with high basal cortisol levels (Miller et al., 2007) . For this purpose, the Trauma Questionnaire (Escalona et al., Figure 1 Flow diagram describing the recruitment process, the exclusion determinants and the patients who completed the study. 1997) was employed, an instrument meant to evaluate a checklist related to traumatic experiences over a lifetime.
Analytical determinations
Biomarkers in saliva samples were measured at T1, T2 and T3, following Strahler et al. (2017) recommendations. Saliva samples were collected between 10 and 12 a.m. (minimum 1 h after breakfast) and kept frozen at −80°C until analysis. Regarding saliva quality, the participants did not show any ear/nose/throat/mouth infection upon collection of the saliva, and analgesic intake by the participants was sporadic. Regarding the status of oral cavities, no participants reported xerostomy or periodontitis.
Standard of cortisol was purchased from Sigma-Aldrich Química SA (Madrid, Spain). The frozen saliva samples were thawed on ice and homogenized. The sample treatment to determine cortisol was based on a previous work (García-Blanco et al., 2016) . Briefly, 25 μL of the sample were subjected to liquid-liquid extraction. Then, the organic layer was evaporated to dryness and the residues were reconstituted in a water (pH 3): methanol (85:15 v/v) solution. Finally, 5 μL were injected in the chromatographic system (ultra-performance liquid chromatography coupled with tandem mass spectrometry) as previously described (García-Blanco et al., 2016) . For this analytical method, the intra-day and inter-day coefficients of variation were 12% (n = 3) and 13% (n = 9), respectively (at a concentration of 20 nmol L −1
). The limit of detection (LOD) obtained for cortisol was 0.05 nmol L −1 , and the limit of quantification (LOQ) was 0.1 nmol L −1 . For the α-amylase measurement, a salivary α-amylase assay kit from Salimetrics (Suffolk, UK) was employed. Saliva samples were thawed on ice, homogenized, vortexed and centrifuged. Then, they were diluted with the α-amylase diluent at 1:200 for the final dilution. Lastly, they were subjected to the kinetic enzyme assay. For this method, the intra-assay coefficients of variation were 2.3% (n = 10) at 475 U mL −1 , 6.7% (n = 10) at 109 U mL −1 and 7.2% (n = 10) at 18 U mL variation were 3.6% (n = 8) at 166 U mL −1 and 5.8% (n = 8) at 11 U mL −1 . The LOD was 0.6 U mL −1 and the LOQ was 2 U mL −1
.
Statistical analysis
Data were summarized using the mean (standard deviation) and median (first third-quartile) in the case of continuous variables and using relative and absolute frequencies in the case of categorical variables. The association between IVF and psychological symptoms (BDI/SF, STAI-S) was assessed using ordinal mixed models (Ananth and Kleinbaum, 1997) . These models are able to leverage the information included in ordinal dependent variables. Meanwhile, the association between IVF and biomarker levels (cortisol, α-amylase) was assessed using linear mixed quantile models to estimate the median (Eilers et al., 2012) . This approach was used instead of linear mixed models because 19% of cortisol values were under the LOD, and therefore, affecting the estimation of the mean, but not of the median. Statistical models included an interaction between group and time to assess differences in the evolution of the different response variables in each group through the studied time range. Firstly, since an interaction has been included in the models, the differences at T1 between both groups are examined. Subsequently, the differences in slopes between both groups from T1 to T2 and from T2 to T3 are analyzed. All models also included age, gestational week at T1, multiple pregnancy, parity and previous miscarriages, as covariates. All statistical analyses were performed using R (version 3.3.2) and the R packages lqmm (version 1.5.3) and ordinal (version 2015.6-28 ). Table I shows the demographic and clinical variables for all participants. The STAI and BDI scores, as well as the cortisol and α-amylase concentrations obtained for each group, are summarized in Table II. The statistical model results are also summarized in Table III .
Results
The ordinal mixed model showed that IVF mothers had higher STAI scores at T1 (P = 0.016, OR = 2.46), and this difference remained mostly steady through T2 and T3, with both groups displaying a parallel decreasing trend with no apparent differences in slopes (P = 0.37, OR = 0.70 and P = 0.36, OR = 0.69) (see Fig. 2a) . In this figure, we can observe the predicted STAI scores for each group at each time. In the case of BDI scores, a large difference between IVF and natural conception mothers was observed at T1; specifically, the natural conception group obtained higher BDI scores (P < 0.001, OR = 0.192). This difference decreases from T1 to T2 and remains constant from T2 to T3, but no statistically significant differences between the slopes of both groups were found (P = 0.072, OR = 2.21 and P = 0.107, OR = 2.09) (see Fig. 2b ). In Fig. 2b , we can also observe the predicted BDI scores for each group at each time.
The quantile regression model for cortisol showed that in our sample, IVF mothers had higher cortisol levels than natural conception mothers at T1 (P = 0.043, Δlog(cortisol) = 0.88). From T1 to T2, both groups followed a similar upwards trend, with no evident differences in slopes (P = 0.81, Δlog(cortisol) = −0.16). However, the progression was different from T2 to T3, with IVF mothers exhibiting a sharper decrease in cortisol levels compared to natural conception mothers, although this difference did not reach statistical significance (P = 0.059, Δlog(cortisol) = −0.94) (see Fig. 3a ). In the case of α-amylase, there was no statistically significant difference between the groups at T1 (P = 0.7, Δlog(α-amylase) = −0.095). From T1 to T2, while IVF mothers showed a mild increase in α-amylase levels, natural conception mothers showed a marked decrease in α-amylase levels (P = 0.049, Δlog(α-amylase) = 0.596). Nevertheless, natural conception mothers showed an increase in α-amylase levels from T2 to T3 that was not evident in the case of IVF mothers, although the difference was not statistically significant (P = 0.53, Δlog(α-amylase) = −0.283) (see Fig. 3b ).
Discussion
Our study shows that IVF women exhibit higher cortisol levels and higher anxiety but lower depressive symptoms during the third trimester of pregnancy, but these differences are negligible during postpartum period. Specifically, IVF women had higher anxiety symptoms than natural conception women at the third trimester of pregnancy. However, both groups displayed a parallel decreasing trend at 48 h and 3 months after birth. Conversely, natural conception women exhibited higher depressive symptoms than IVF women at the third trimester of pregnancy and this difference was maintained until 3 months after birth. In the case of stress biomarkers, IVF women had higher cortisol levels than natural conception women at the third trimester of pregnancy but their levels decreased after giving birth. There was no difference between the groups in terms of α-amylase values at the third trimester of pregnancy, but they sharply decreased until 48 h after giving birth in the case of natural conception women compared to IVF women. Then, until 3 months after birth, α-amylase levels tended to increase in natural conception compared with IVF women. Regarding psychological symptoms, our findings showed that the differences between IVF women and natural conception women depend on the time of testing: IVF women exhibited higher anxiety levels at the third trimester of pregnancy compared to natural conception women in accordance with a number of previous studies (Monti et al., 2008; Gourounti et al., 2013; Hashemiech et al., 2013; Darwiche et al., 2014) . Similarly, a recent updated review shows greater anxiety during pregnancy in IVF women than in natural conception women (Gourounti, 2016) , which has been associated with concern for the security of pregnancy, fetal health and delivery Glazebrook et al., 2001) . IVF women reached clinically significant anxiety symptoms at the third trimester of pregnancy, which indicates that they are vulnerable to stress during pregnancy. In contrast, both groups showed a decrease of anxiety levels after birth. This result is in concordance with what was observed in earlier studies, which suggested that these symptoms decrease rapidly after birth (JongbloedPereboom et al., 2012) . According to depressive symptoms, IVF women showed lower levels at the third trimester of pregnancy. This difference tended to decrease from pregnancy to 48 h after giving birth (for similar findings, see Harf-Kashdaei and Kaitz, 2007; Punamäki et al., 2006; Fisher et al., 2008; Gameiro et al., 2010; Gourounti, 2016; McMahon et al., 2013; Lynch and Prasad, 2014) . A decrease in depressive symptoms may reflect a satisfactory adjustment in attitudes regarding pregnancy and motherhood (Gourounti, 2016) . Previous research has suggested that mothers who have been exposed to IVF treatment and have had a successful outcome were more resilient than mothers who conceived naturally (Repokari et al., 2005) . Furthermore, women after successful IVF may be more grateful for being pregnant, which may hinder expressions of sadness and increase happiness (Ulrich et al., 2004) .
Women subjected to IVF showed a trend toward higher cortisol levels at the third trimester of pregnancy. Although IVF treatment triggers HPA-axis impairment and subsequently increases cortisol levels (Lovely et al., 2003; Hellgren et al., 2016) , these are transitional effects. Indeed, cortisol increase in IVF pregnant women tended to reverse at 3 months after giving birth. Likewise, although similar α-amylase levels were identified in both groups, the natural conception group showed a trend toward increasing α-amylase levels at 3 months after giving birth. Therefore, whereas postpartum cortisol levels decrease in IVF mothers, postpartum α-amylase levels increase in natural conception mothers. As cortisol levels indicate, stress-related metabolism, immunological and psychological functions may be recovered in IVF women after a delivery without complications (Herman et al., 2016) . In contrast, as α-amylase levels indicate, when natural conception women have to face motherhood, SAM axis may be over-activated, triggering an acute physiological response to stress (Giesbrecht et al., 2013) . Previous research indicates that IVF mothers may show higher tolerance for psychosocial stressors than natural conception mothers because IVF mothers have already faced negative emotions during the infertility period (Harris et al., 1991; Sandelowski et al., 1992) . Therefore, natural conception mothers may be more vulnerable to parenting stress than IVF mothers (Darwiche et al., 2014) .
Our study is strengthened by the fact that we examined both biological and psychological stress at different points of time taking into account other stress-generating factors (age, gestational week at T1, multiple pregnancy, parity and previous miscarriages). Conversely, our results could not be generalized to women with very preterm birth because participants were recruited during the third trimester of pregnancy. Furthermore, although the heterogeneity in the IVF group may be a limitation, it makes our results more generalizable. Therefore, further research is needed to consolidate these preliminary results.
To conclude, IVF is a stressful event that influences women during pregnancy, as evidenced by the presence of high cortisol levels and anxiety symptoms at the third trimester of pregnancy. Contrarily, successful IVF is associated with a decrease of prenatal depression. However, IVF does not seem to have a negative influence during the postpartum period if a satisfactory delivery has been achieved. In fact, stress biomarker levels are lower in IVF than in natural conception mothers during motherhood. Clinically significant anxiety and HPAaxis dysregulation during pregnancy have been associated with an increased risk of neurodevelopment newborn impairment (Zijlmans et al., 2015) . In clinical practice, obstetricians and midwives should pay attention to these symptoms in IVF pregnant women, despite postpartum adjustment. Therefore, psychological therapy should be extended during pregnancy in IVF women to improve cognitivebehavioral coping strategies.
